TrialClinical and translational science2025

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Profiles of a Single-Dose JYB1904 in Healthy Chinese Participants: A Phase Ia, Randomized, Double-Blind, Placebo-Controlled Study.

Zhen-Wei Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.